StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) stock

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.50−0.18 (-10.71%)

Close on Nov 18, 2026Market cap $1.01MP/E –Yield –

Artelo Biosciences market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Artelo Biosciences's market cap was $1.48M on Nov 11, 2026, against $73.08M a year earlier. Over the last 5 years it ranged from $1.48M to $343.67M, with a median of $116.78M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.48M-97.1%
2025Dec 31, 2025$51.24M-44.5%
2024Dec 31, 2024$92.38M-22.7%
2023Dec 29, 2023$119.54M-6.3%
2022Dec 30, 2022$127.59M-62.9%
2021Dec 31, 2021$343.67M-76.7%
2020Dec 31, 2020$1.48B-59.8%
2019Dec 31, 2019$3.67B-43.8%
2018Dec 31, 2018$6.52B+42.2%
2017Dec 29, 2017$4.59B–

More Artelo Biosciences figures

See a number that looks wrong?